• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Tyrosine Kinase Inhibitor-Induced Intracranial Artery Stenosis - A Rare Cause of TIA in a Patient of Chronic Myeloid Leukemia.

作者信息

Agrawal Sumedh S, Shetty Nikith A, Shenoy Nisha, Prabhu Arvind N, Pai Aparna R

机构信息

Department of Medicine, Shri Bhausaheb Hire Government Medical College and Hospital, Dhule, Maharashtra, India.

Department of Neurology, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal, Karnataka, India.

出版信息

Ann Indian Acad Neurol. 2024 Nov 1;27(6):740-742. doi: 10.4103/aian.aian_411_24. Epub 2024 Oct 8.

DOI:10.4103/aian.aian_411_24
PMID:39377246
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11745260/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f70/11745260/644552d2ded0/AIAN-27-740-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f70/11745260/644552d2ded0/AIAN-27-740-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f70/11745260/644552d2ded0/AIAN-27-740-g001.jpg

相似文献

1
Tyrosine Kinase Inhibitor-Induced Intracranial Artery Stenosis - A Rare Cause of TIA in a Patient of Chronic Myeloid Leukemia.酪氨酸激酶抑制剂诱导的颅内动脉狭窄——慢性髓系白血病患者短暂性脑缺血发作的罕见病因
Ann Indian Acad Neurol. 2024 Nov 1;27(6):740-742. doi: 10.4103/aian.aian_411_24. Epub 2024 Oct 8.
2
Intracranial stenting for nilotinib treatment-associated cerebrovascular stenosis in chronic myeloid leukemia.颅内支架置入术治疗慢性髓性白血病中与尼罗替尼治疗相关的脑血管狭窄
Interv Neuroradiol. 2017 Oct;23(5):527-530. doi: 10.1177/1591019917710810. Epub 2017 Jun 5.
3
Cerebrovascular stenosis related to tyrosine kinase inhibitor for chronic myeloid leukemia: two illustrative cases.慢性髓性白血病酪氨酸激酶抑制剂相关的脑血管狭窄：两例说明性病例
BMC Neurol. 2025 Jan 3;25(1):6. doi: 10.1186/s12883-024-04006-2.
4
Tyrosine kinase inhibitor induced rapidly progressive vasculopathy after intracranial stent placement.酪氨酸激酶抑制剂诱导颅内支架置入后快速进展性血管病。
J Neurointerv Surg. 2018 Nov;10(11):e28. doi: 10.1136/neurintsurg-2018-013777.rep. Epub 2018 Apr 7.
5
Tyrosine kinase inhibitor induced rapidly progressive vasculopathy after intracranial stent placement.酪氨酸激酶抑制剂在颅内支架置入后诱发快速进展性血管病变。
BMJ Case Rep. 2018 Apr 3;2018:bcr-2018-013777. doi: 10.1136/bcr-2018-013777.
6
[Practical management of side effects of tyrosine kinase inhibitor therapy in chronic myeloid leukemia].[慢性髓性白血病酪氨酸激酶抑制剂治疗副作用的实际管理]
Orv Hetil. 2021 Jul 25;162(30):1198-1207. doi: 10.1556/650.2021.32177.
7
Medication adherence among adults prescribed imatinib, dasatinib, or nilotinib for the treatment of chronic myeloid leukemia.接受伊马替尼、达沙替尼或尼洛替尼治疗慢性髓性白血病的成年人的药物依从性。
J Oncol Pharm Pract. 2015 Feb;21(1):19-25. doi: 10.1177/1078155213520261. Epub 2014 Feb 6.
8
Bilateral renal artery stenosis in a patient with chronic myeloid leukemia treated with nilotinib.使用尼罗替尼治疗的慢性髓性白血病患者出现双侧肾动脉狭窄。
Leuk Res Rep. 2012 Nov 10;1(1):1-3. doi: 10.1016/j.lrr.2012.09.002. eCollection 2012.
9
Tyrosine kinase inhibitor-induced carotid stenosis: A case report.酪氨酸激酶抑制剂诱发的颈动脉狭窄：一例报告。
Leuk Res Rep. 2019 May 25;12:100171. doi: 10.1016/j.lrr.2019.100171. eCollection 2019.
10
Tyrosine kinase inhibitor therapy can cure chronic myeloid leukemia without hitting leukemic stem cells.酪氨酸激酶抑制剂治疗可以治愈慢性髓性白血病而不影响白血病干细胞。
Haematologica. 2010 Jun;95(6):900-7. doi: 10.3324/haematol.2009.015271. Epub 2009 Dec 8.

本文引用的文献

1
How do neurologists diagnose transient ischemic attack: A systematic review.神经科医生如何诊断短暂性脑缺血发作：系统评价。
Int J Stroke. 2019 Feb;14(2):115-124. doi: 10.1177/1747493018816430. Epub 2018 Dec 3.
2
Tyrosine kinase inhibitor induced rapidly progressive vasculopathy after intracranial stent placement.酪氨酸激酶抑制剂在颅内支架置入后诱发快速进展性血管病变。
BMJ Case Rep. 2018 Apr 3;2018:bcr-2018-013777. doi: 10.1136/bcr-2018-013777.
3
Intracranial stenting for nilotinib treatment-associated cerebrovascular stenosis in chronic myeloid leukemia.
颅内支架置入术治疗慢性髓性白血病中与尼罗替尼治疗相关的脑血管狭窄
Interv Neuroradiol. 2017 Oct;23(5):527-530. doi: 10.1177/1591019917710810. Epub 2017 Jun 5.
4
Diagnosis and Management of Transient Ischemic Attack.短暂性脑缺血发作的诊断与管理
Continuum (Minneap Minn). 2017 Feb;23(1, Cerebrovascular Disease):82-92. doi: 10.1212/CON.0000000000000424.
5
Extensive intracranial arterial stenoses in conjunction with the use of tyrosine kinase inhibitor Nilotinib.广泛颅内动脉狭窄与酪氨酸激酶抑制剂尼罗替尼的使用相关。
Clin Case Rep. 2016 Nov 9;4(12):1184-1186. doi: 10.1002/ccr3.729. eCollection 2016 Dec.
6
Tyrosine Kinase Inhibitor-Associated Cardiovascular Toxicity in Chronic Myeloid Leukemia.酪氨酸激酶抑制剂相关的慢性髓性白血病心血管毒性
J Clin Oncol. 2015 Dec 10;33(35):4210-8. doi: 10.1200/JCO.2015.62.4718. Epub 2015 Sep 14.
7
Nilotinib treatment-associated cerebrovascular disease and stroke.尼罗替尼治疗相关的脑血管疾病和中风。
Am J Hematol. 2013 Jun;88(6):534-5. doi: 10.1002/ajh.23442. Epub 2013 May 13.
8
Nilotinib: a second-generation tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia.尼洛替尼：一种用于治疗慢性粒细胞白血病的第二代酪氨酸激酶抑制剂。
Clin Ther. 2008 Nov;30(11):1956-75. doi: 10.1016/j.clinthera.2008.11.014.